Ligand validation:4NZD

MAN: alpha-D-mannopyranose

MAN is a Ligand Of Interest in 4NZD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4NZD_MAN_C_301	72%	52%	0.125	0.964	0.81	1.03	1	2	1	0	92%	0.9167
4NZD_MAN_A_301	61%	46%	0.134	0.937	1.04	1.08	1	1	0	0	92%	0.9167
4NZD_MAN_B_301	44%	39%	0.192	0.937	1.37	1.06	1	1	2	0	92%	0.9167
3TGX_MAN_M_304	36%	34%	0.2	0.909	0.85	1.84	1	5	0	0	92%	0.9167
1GAI_MAN_A_480	100%	74%	0.043	0.986	0.45	0.53	-	-	0	0	100%	0.9167
5M03_MAN_A_402	99%	59%	0.034	0.989	0.56	0.99	-	-	0	0	92%	0.9167
1GAH_MAN_A_479	99%	76%	0.05	0.989	0.44	0.5	-	-	0	0	100%	0.9167
1BXO_MAN_A_328	99%	39%	0.05	0.985	1.37	1.08	1	1	0	0	100%	0.9167
7LTB_MAN_B_101	99%	58%	0.053	0.985	0.73	0.85	-	1	0	0	100%	0.9167

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.